全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
药学学报  2013 

化合物效率与先导物优化

, PP. 1755-1762

Keywords: 化合物效率,成药性,微观结构,慢离解药物

Full-Text   Cite this paper   Add to My Lib

Abstract:

活性和成药性是药物的两大支柱,分别是由分子的微观结构与宏观性质所决定。结构的优化是在多维度空间中进行的多参数分子操作。由体外活性过渡到体内的药理效应有许多不确定性,需要在早期优化阶段用分子的多维度规(metrics)评价化合物的质量或效率。本文在讨论表征化合物活性和成药性参数的基础上,阐述调整微观结构中药物-受体结合热力学的焓与熵、结合动力学的离解速率对提高化合物效率的影响,说明优化微观结构对成药性的重要意义。

References

[1]  nissinkjwm.simplesize-independentmeasureofligandefficiency[j].jcheminfmodel,2009,49:1617-1622.
[2]  reynoldsch,toungeba,bembeneksd.ligandbindingefficiency:trends,physicalbasis,andimplications[j].jmedchem,2008,51:2432-2438.
[3]  howards,berdiniv,boulstridgeja,etal.fragment-baseddiscoveryofthepyrazol-4-ylurea(at9283),amultitargetedkinaseinhibitorwithpotentaurorakinaseactivity[j].jmedchem,2009,52:379-388.
[4]  ryckmanst,edwardsmp,horneva,etal.rapidassessmentofanovelseriesofselectivecb2agonistsusingparallelsynthesisprotocols:alipophilicefficiency(lipe)analysis[j].bioorgmedchemlett,2009,19:4406-4409.
[5]  leesonp,springthorpeb.theinfluenceofdrug-likeconceptsondecision-makinginmedicinalchemistry[j].natrevdrugdiscov,2007,6:881-890.
[6]  edwardsmp,priceda.roleofphysicochemicalpropertiesandligandlipophilicityefficiencyinaddressingdrugsafetyrisks[j].annurepmedchem,2010,45:381-391.
[7]  perodae.ananalysisofthebindingefficienciesofdrugsandtheirleadsinsuccessfuldrugdiscoveryprograms[j].jmedchem,2010,53:2986-2997.
[8]  keserügm,makaragm.theinfluenceofleaddiscoverystrategiesonthepropertiesofdrugcandidates[j].natrevdrugdiscov,2009,8:203-212.
[9]  tieyp,borosspi,wangl,etal.highresolutioncrystalstructuresofhiv-1proteasewithapotentnon-peptideinhibitor(uic-94017)activeagainstmulti-drug-resistantclinicalstrains[j].jmolbiol,2004,338:341-352.
[10]  lafontv,armstrongaa,ohtakah,etal.compensatingenthalpicandentropicchangeshinderbindingaffinityoptimization[j].chembioldrugdes,2007,69:413-422.
[11]  wangay,dorsoc,kopchol,etal.potency,selectivityandprolongedbindingofsaxagliptintodpp4:maintenanceofdpp4inhibitionbysaxagliptininvitroandexvivowhencomparedtoarapidly-dissociatingdpp4inhibitor[j].bmcpharmacol,2012,12:2.
[12]  dowlingmr,charltonsj.quantifyingtheassociationanddissociationratesofunlabelledantagonistsatthemuscarinicm3receptor[j].brjpharmacol,2006,148:1134-1142.
[13]  lumerasw,vidall,vidalb,etal.1,7-naphthyridine1-oxidesasnovelpotentandselectiveinhibitorsofp38mitogenactivatedproteinkinase[j].jmedchem,2011,54:7899-7910.
[14]  hannmm.molecularobesity,potencyandotheraddictionsindrugdiscovery[j].medchemcomm,2011,2:349-355.
[15]  guozr.strategyofmoleculardrugdesign:activityanddruggability[j].actapharmsin(药学学报),2010,45:539-547.
[16]  guozr.strategyofmoleculardesignofdrugs:theunificationofmacro-propertiesandmicro-structuresofamolecule[j].actapharmsin(药学学报),2008,43:227-233.
[17]  guozr.toxicityrisksanddrugdesign[j].progpharmsci(药学进展),2012,36:1-13.
[18]  hopkinsal,groomcr,alexa.ligandefficiency:ausefulmetricforleadselection[j].drugdiscovtoday,2004,9:430-431.
[19]  abad-zapateroc,peri?i?o,wassjl,etal.ligandefficiencyindicesforaneffectivemappingofchemico-biologicalspace:theconceptofanatlas-likerepresentation[j].drugdiscovtoday,2010,15:804-811.
[20]  reynoldsch,bembeneksd,toungeba.theroleofmolecularsizeinligandefficiency[j].bioorgmedchemlett,2007,17:4258-4261.
[21]  reynoldsch,hollowaymk.thermodynamicsofligandbindingandefficiency[j].acsmedchemlett,2011,2:433-437.
[22]  ohtakah,freiree.adaptiveinhibitorsofthehiv-1protease[j].progbiophysmolbiol,2005,88:193-208.
[23]  baumb,muleyl,heinea,etal.thinktwice:understandingthehighpotencyofbis(phenyl)methaneinhibitorsofthrombin[j].jmolbiol,2009,391:552-564.
[24]  copelandra.thedynamicsofdrug-targetinteractions:drug-targetresidencetimeanditsimpactonefficacyandsafety[j].expertopindrugdiscov,2010,5:305-310.
[25]  weikltr,vondeusterc.selected-fitversusinduced-fitproteinbinding:kineticdifferencesandmutationalanalysis[j].proteins,2009,75:104-110.
[26]  csermelyp,palotair,nussinovr.inducedfit,conformationalselectionandindependentdynamicsegments:anextendedviewofbindingevents[j].trendbiochemsci,2010,35:539-546.
[27]  tumminopj,copelandra.residencetimeofreceptor-ligandcomplexesanditseffectonbiologicalfunction[j].biochemistry,2008,47:5481-5492.
[28]  tanaka-aminok,matsumotok,hatakeyamay,etal.asp4000,aslow-bindingdipeptidylpeptidase4inhibitor,hasantihyperglycemicactivityoflongdurationinzuckerfattyrats[j].actadiabetol,2010,47:43-48.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133